Audience-funded nonprofit news
Next Up:
0:00
0:00
-
Listen Listen
Health
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
Sponsored message
More Stories
-
More than 1 in 10 adults who had COVID have had symptoms for at least a year.
-
Researchers find that many common strategies for increasing happiness may not be supported by strong evidence.
-
The monoclonal antibody drug prevents the lung infection that puts 58,000 to 80,000 young children in the hospital each year.
-
L.A. sees "slight increase" in ER visits
-
The flea-borne disease is on the rise in L.A.
-
Thanks to the James Webb telescope, we can now see the nebula with more clarity. As one expert says, "We always knew planetary nebulae were pretty. What we see now is spectacular."
-
Frustration runs deep among medical cannabis patients and advocates who say the commercial market created by Proposition 64 in 2016 isn’t meeting their needs.
-
Social and economic pressures have long compelled Black girls and women to straighten their hair to conform to Eurocentric beauty standards. But chemical straighteners are stinky and costly and sometimes cause painful scalp burns. Mounting evidence now shows they could be a health hazard.
-
Some hospitals in Southern California have a nurse vacancy rate of 30%, stressing overworked staff and causing some to leave the industry earlier than they planned.
-
Thousands of striking Hollywood actors and writers are risking their health insurance as the labor dispute continues.
-
Lower deductibles, copays and medicine costs to come.
-
Emergency rooms report when patients visit with health problems caused by heat. Find out when and where rates of illness are spiking, and explore trends over the last five years.
